Canopy Growth Launches New Spectrum Therapeutics Softgels in Australia
Canopy Growth Corporation has expanded its Spectrum Therapeutics portfolio in Australia by launching new softgel capsules for medical cannabis patients. The new products include Spectrum Yellow, Red, and Blue Cannabis Oil Softgels, offering various CBD and THC combinations. This expansion aims to provide more choices for patients and prescribers, reinforcing Canopy Growth's commitment to its international medical cannabis business. The softgels are available through authorized prescribers in Australia.
Canopy Growth Corporation has expanded its Spectrum Therapeutics portfolio in Australia by introducing new softgel capsules for medical cannabis patients. The new products include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis Oil Softgels (THC 10mg), and Spectrum Blue Cannabis Oil Softgels (balanced THC 2.5mg : CBD 3.75mg). These additions complement the company’s existing range of oils and flower products available to Australian patients. The expansion aims to provide patients and prescribers with more choices and reinforces Canopy Growth’s commitment to supporting the growth of its international medical cannabis business. The softgels are now available in Australia through authorized prescribers. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canopy Growth Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251117907024) on November 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
